Acsessa Limited was set up on Thursday the 5th of March 2020. Their current partial address is Dublin 2, and the company status is Normal. The company's current directors have been the director of 0 other Irish companies between them. Acsessa Limited has 2 shareholders. This Irish company shares its Eircode with at least 115 other companies.
Company Name: | Acsessa Limited |
Company Status: | NORMAL |
Company Address: | Pembroke House, 28-32 Pembroke Street Upper, Dublin 2 |
Key Executive: | Mr Vaporean |
Company Size: | Log-In To View |
Mr Vaporean is a Company Director of Acsessa Limited since 2020
Generate a B2B Marketing List with ease and grow your business. Identify key decision makers and pre-qualified new prospects for your sales and business development teams.
Similar Companies - Create a marketing list of similar companies
The latest documents filed with the Companies Registration Office for Acsessa Limited (which can include the Account Details) are listed below.
View CRO company documents and company reports any Irish company or business with ease.
Satisfy due diligence requirements on Acsessa Limited in one single 'time-saving' search. Run full background checks for Fitness and Probity on the directors of Acsessa Limited and Anti-Money Laundering checks (AML checks) on Acsessa Limited
Company Type: | LTD - Private Company Limited By Shares |
Number of Shareholders: | 2 |
Log-in now to run Due Diligence checks and Compliance checks on Acsessa Limited or click Join-up to get started.
Background check Companies, Sole Traders or Individuals and minimise your spend with more efficient Anti-Money Laundering checks and reports.
28/07/2025
Looking to achieve better and cleaner data? CRIFVision-net helps you get the most out of your data.
14/07/2025
For the first six months of 2025, a 9% year-on-year increase of company start-ups was recorded.
07/07/2025
According to our latest figures a 9% year-on-year increase in the number of company start-ups
30/06/2025
Over the past six months, Ireland has seen a modest decline in new directorship appointments.